Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenue:    
Total revenue $ 5,918,599 $ 4,282,901
Costs and expenses:    
Cost of ancillary products and assembled components 52,590 14,304
Selling, general and administrative 3,043,359 2,711,052
Research and development 199,070 118,701
Depreciation and amortization 724,462 717,254
Share-based compensation 310,002 316,640
Total costs and expenses 4,329,483 3,877,951
Income from operations 1,589,116 404,950
Other income (expense):    
Interest income 2,233 382
Interest expense (1,687,022) (180,910)
Share redemption consideration   (195,482)
Foreign currency exchange loss (60,263) (8,975)
Change in fair value of interest rate swap liability   49,822
Total other expense, net (1,745,052) (335,163)
(Loss) income before benefit for income taxes (155,936) 69,787
Benefit for income taxes 141,974 18,950
Net (loss) income (13,962) 88,737
Foreign currency translation adjustment (41,949) (79,207)
Comprehensive (loss) income $ (55,911) $ 9,530
Net (loss) income per share:    
Basic $ 0.00 $ 0.00
Diluted $ 0.00 $ 0.00
Weighted-average shares outstanding:    
Basic 24,405,278 18,838,221
Diluted 24,405,278 20,173,443
Licensing Fees    
Revenue:    
Total revenue $ 5,918,599 $ 4,282,901